36 related articles for article (PubMed ID: 2729631)
1. Relative potency of some neuromuscular blocking drugs in vivo and in vitro.
Anttila P; Ertama P
Med Biol; 1978 Jun; 56(3):152-5. PubMed ID: 682698
[TBL] [Abstract][Full Text] [Related]
2. The effect of various dilute administration of rocuronium bromide on both vascular pain and pharmacologic onset: a randomized controlled trial.
Kanazawa M; Sato Boku A; Okumura Y; Hashimoto M; Tachi N; Adachi Y; Okuda M
BMC Anesthesiol; 2019 May; 19(1):76. PubMed ID: 31092196
[TBL] [Abstract][Full Text] [Related]
3. Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents.
Kim YB; Sung TY; Yang HS
Korean J Anesthesiol; 2017 Oct; 70(5):500-510. PubMed ID: 29046769
[TBL] [Abstract][Full Text] [Related]
4. Simulation of the kinetics of neuromuscular block: implications for speed of onset.
Dilger JP
Anesth Analg; 2013 Oct; 117(4):792-802. PubMed ID: 23456666
[TBL] [Abstract][Full Text] [Related]
5. Rapacuronium bromide: a review of its use in anaesthetic practice.
Onrust SV; Foster RH
Drugs; 1999 Nov; 58(5):887-918. PubMed ID: 10595867
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacokinetics of cisatracurium besilate.
Kisor DF; Schmith VD
Clin Pharmacokinet; 1999 Jan; 36(1):27-40. PubMed ID: 9989341
[TBL] [Abstract][Full Text] [Related]
7. Cisatracurium besilate. A review of its pharmacology and clinical potential in anaesthetic practice.
Bryson HM; Faulds D
Drugs; 1997 May; 53(5):848-66. PubMed ID: 9129870
[TBL] [Abstract][Full Text] [Related]
8. Neuromuscular transmission and its pharmacological blockade. Part 1: Neuromuscular transmission and general aspects of its blockade.
Booij LH
Pharm World Sci; 1997 Feb; 19(1):1-12. PubMed ID: 9089749
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic analysis of contractile potentiation by cholinesterase inhibitors in rats.
Yamamoto K; Sawada Y; Iga T
J Pharmacokinet Biopharm; 1996 Aug; 24(4):327-48. PubMed ID: 9044164
[TBL] [Abstract][Full Text] [Related]
10. An extended pharmacokinetic/pharmacodynamic model describing quantitatively the influence of plasma protein binding, tissue binding, and receptor binding on the potency and time course of action of drugs.
Proost JH; Wierda JM; Meijer DK
J Pharmacokinet Biopharm; 1996 Feb; 24(1):45-77. PubMed ID: 8827583
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic behaviour of rocuronium in the elderly.
Bevan DR; Fiset P; Balendran P; Law-Min JC; Ratcliffe A; Donati F
Can J Anaesth; 1993 Feb; 40(2):127-32. PubMed ID: 8443851
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacology of ORG 7617, a short-acting non-depolarizing neuromuscular blocking agent.
van den Broek L; Wierda JM; Proost JH; Hommes FD; Agoston S
Eur J Clin Pharmacol; 1994; 46(3):225-9. PubMed ID: 7915236
[TBL] [Abstract][Full Text] [Related]
13. Preliminary investigations of the clinical pharmacology of three short-acting non-depolarizing neuromuscular blocking agents, Org 9453, Org 9489 and Org 9487.
Wierda JM; Beaufort AM; Kleef UW; Smeulers NJ; Agoston S
Can J Anaesth; 1994 Mar; 41(3):213-20. PubMed ID: 7910526
[TBL] [Abstract][Full Text] [Related]
14. In vitro potency and mode of action of ANQ9040: a novel fast acting muscle relaxant.
Lees G; Munday IT; Edwards MD; Jones RM
Br J Pharmacol; 1994 Oct; 113(2):642-8. PubMed ID: 7834218
[TBL] [Abstract][Full Text] [Related]
15. A kinetic-dynamic model to explain the relationship between high potency and slow onset time for neuromuscular blocking drugs.
Donati F; Meistelman C
J Pharmacokinet Biopharm; 1991 Oct; 19(5):537-52. PubMed ID: 1783991
[TBL] [Abstract][Full Text] [Related]
16. Rocuronium (ORG 9426) neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis in humans.
Meistelman C; Plaud B; Donati F
Can J Anaesth; 1992 Sep; 39(7):665-9. PubMed ID: 1394754
[TBL] [Abstract][Full Text] [Related]
17. Pancuronium, gallamine, and d-tubocurarine compared: is speed of onset inversely related to drug potency?
Kopman AF
Anesthesiology; 1989 Jun; 70(6):915-20. PubMed ID: 2729631
[TBL] [Abstract][Full Text] [Related]
18. Interactions of gallamine and pancuronium with tubocurarine under morphine-nitrous oxide-oxygen anesthesia in man.
Park WY; Balingit PE; Macnamara TE
Anesth Analg; 1974; 53(5):723-9. PubMed ID: 4472154
[No Abstract] [Full Text] [Related]
19. Time course of muscle relaxation with a combination of pancuronium and tubocurarine.
Mirakhur RK; Pandit SK; Ferres CJ; Gibson FM
Anesth Analg; 1984 Apr; 63(4):437-40. PubMed ID: 6703370
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
